Serum amyloid P component, C reactive protein, and serum amyloid A in patients with systemic lupus erythematosus, rheumatoid arthritis, and Wegener’s granulomatosis
| SLE (n = 40) | Rheumatoid arthritis (n = 31) | Wegener’s granulomatosis (n = 25) | ||||
|---|---|---|---|---|---|---|
| Active | Inactive | Active | Inactive | Active | Inactive | |
| Paired analysis of SAP, C reactive protein, and SAA detected in patients with SLE, rheumatoid arthritis, and Wegener’s granulomatosis patients during active and inactive disease. Values are mean (SD), mg/dl. | ||||||
| **p<0.01, ***p<0.001, paired t test. | ||||||
| SAA, serum amyloid A; SAP, serum amyloid P; SLE, systemic lupus erythematosus. | ||||||
| SAP | 27.8 (11.3) | 26.4 (11.4) | 32.3 (12.3) | 30.3 (19.3) | 40.4 (13.9) | 39.3 (12.3) |
| C reactive protein | 32.6 (64.5)*** | 9.3 (15.9) | 22.7 (23.1)* | 14.3 (12.6) | 131.3 (132.6)*** | 16.5 (19.4) |
| SAA | 23.4 (40.1)*** | 9.7 (24.3) | 40.9 (49.5) | 26.4 (32.0) | 339.3 (349.1)*** | 35.5 (78.1) |